VRNA - Verona Pharma gets $650M in financing ahead of June FDA decision on COPD asset
2024-05-09 13:54:49 ET
More on Verona Pharma
- Verona Pharma plc (VRNA) Q1 2024 Earnings Call Transcript
- Verona Pharma plc (VRNA) Q4 2023 Earnings Call Transcript
- Verona Pharma plc 2023 Q4 - Results - Earnings Call Presentation
- Verona Pharma GAAP EPS of -$0.04 beats by $0.09
- Seeking Alpha’s Quant Rating on Verona Pharma